# Selective Insurance Group Inc: financial statements, quarterly

SIGI · Nasdaq · CIK 230557 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sigi.md) · [Financials](/companies/sigi/financials.md) · [Filings](/companies/sigi/filings.md) · [Insiders](/companies/sigi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sigi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,111 d](/filings/0000230557-26-000006.md) | [1,165](/filings/0000230557-25-000010.md) | [1,196](/filings/0000230557-25-000019.md) | [1,244](/filings/0000230557-25-000025.md) | [1,256 d](/filings/0000230557-26-000006.md) | [1,285](/filings/0000230557-26-000011.md) | [1,327](/filings/0000230557-26-000020.md) | [1,360](/filings/0000230557-26-000027.md) | [1,365 d](/filings/0000230557-26-000006.md) | [1,359](/filings/0000230557-26-000011.md) | [1,387](/filings/0000230557-26-000020.md) | [1,326](/filings/0000230557-26-000027.md) |
| Income tax | $m | [32.1 d](/filings/0000230557-26-000006.md) | [20.0](/filings/0000230557-25-000010.md) | [(16.8)](/filings/0000230557-25-000019.md) | [24.2](/filings/0000230557-25-000025.md) | [23.5 d](/filings/0000230557-26-000006.md) | [29.0](/filings/0000230557-26-000011.md) | [23.0](/filings/0000230557-26-000020.md) | [30.4](/filings/0000230557-26-000027.md) | [40.9 d](/filings/0000230557-26-000006.md) | [26.5](/filings/0000230557-26-000011.md) | [33.5](/filings/0000230557-26-000020.md) | [33.4](/filings/0000230557-26-000027.md) |
| Net income | $m | [125 d](/filings/0000230557-26-000006.md) | [82.5](/filings/0000230557-25-000010.md) | [(63.3)](/filings/0000230557-25-000019.md) | [92.3](/filings/0000230557-25-000025.md) | [95.5 d](/filings/0000230557-26-000006.md) | [110](/filings/0000230557-26-000011.md) | [85.9](/filings/0000230557-26-000020.md) | [115](/filings/0000230557-26-000027.md) | [155 d](/filings/0000230557-26-000006.md) | [97.7](/filings/0000230557-26-000011.md) | [129](/filings/0000230557-26-000020.md) | [129](/filings/0000230557-26-000027.md) |
| Diluted EPS | $ per share | not reported | [1.31](/filings/0000230557-25-000010.md) | [(1.08)](/filings/0000230557-25-000019.md) | [1.47](/filings/0000230557-25-000025.md) | not reported | [1.76](/filings/0000230557-26-000011.md) | [1.36](/filings/0000230557-26-000020.md) | [1.85](/filings/0000230557-26-000027.md) | not reported | [1.58](/filings/0000230557-26-000011.md) | [2.11](/filings/0000230557-26-000020.md) | [2.11](/filings/0000230557-26-000027.md) |
| Basic EPS | $ per share | not reported | [1.32](/filings/0000230557-25-000010.md) | [(1.08)](/filings/0000230557-25-000019.md) | [1.48](/filings/0000230557-25-000025.md) | not reported | [1.77](/filings/0000230557-26-000011.md) | [1.37](/filings/0000230557-26-000020.md) | [1.87](/filings/0000230557-26-000027.md) | not reported | [1.59](/filings/0000230557-26-000011.md) | [2.13](/filings/0000230557-26-000020.md) | [2.13](/filings/0000230557-26-000027.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0000230557-25-000006.md) | [0.0](/filings/0000230557-24-000012.md) | [0.0](/filings/0000230557-24-000021.md) | [0.0](/filings/0000230557-24-000026.md) | [0.0](/filings/0000230557-26-000006.md) | [0.0](/filings/0000230557-25-000010.md) | [0.0](/filings/0000230557-25-000019.md) | [0.0](/filings/0000230557-25-000025.md) | [0.0](/filings/0000230557-26-000027.md) | [0.0](/filings/0000230557-26-000011.md) | [0.0](/filings/0000230557-26-000020.md) | [0.0](/filings/0000230557-26-000027.md) |
| Total assets | $bn | [11.8](/filings/0000230557-25-000006.md) | [12.1](/filings/0000230557-24-000012.md) | [12.6](/filings/0000230557-24-000021.md) | [13.5](/filings/0000230557-24-000026.md) | [13.5](/filings/0000230557-26-000006.md) | [14.2](/filings/0000230557-25-000010.md) | [14.5](/filings/0000230557-25-000019.md) | [15.0](/filings/0000230557-25-000025.md) | [15.2](/filings/0000230557-26-000027.md) | [15.3](/filings/0000230557-26-000011.md) | [15.6](/filings/0000230557-26-000020.md) | [15.7](/filings/0000230557-26-000027.md) |
| Total liabilities | $bn | [8.8](/filings/0000230557-25-000006.md) | [9.0](/filings/0000230557-24-000012.md) | [9.6](/filings/0000230557-24-000021.md) | [10.3](/filings/0000230557-24-000026.md) | [10.4](/filings/0000230557-26-000006.md) | [10.9](/filings/0000230557-25-000010.md) | [11.1](/filings/0000230557-25-000019.md) | [11.5](/filings/0000230557-25-000025.md) | [11.5](/filings/0000230557-26-000027.md) | [11.7](/filings/0000230557-26-000011.md) | [12.0](/filings/0000230557-26-000020.md) | [12.3](/filings/0000230557-26-000027.md) |
| Long-term debt | $bn | [0.5](/filings/0000230557-25-000006.md) | not reported | not reported | not reported | [0.5](/filings/0000230557-25-000006.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.0](/filings/0000230557-26-000006.md) | [3.0](/filings/0000230557-25-000010.md) | [2.9](/filings/0000230557-25-000019.md) | [3.2](/filings/0000230557-25-000025.md) | [3.1](/filings/0000230557-26-000006.md) | [3.3](/filings/0000230557-26-000011.md) | [3.4](/filings/0000230557-26-000020.md) | [3.5](/filings/0000230557-26-000027.md) | [3.6](/filings/0000230557-26-000027.md) | [3.6](/filings/0000230557-26-000011.md) | [3.7](/filings/0000230557-26-000020.md) | [3.4](/filings/0000230557-26-000027.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [237 d](/filings/0000230557-26-000006.md) | [114](/filings/0000230557-25-000010.md) | [266 d](/filings/0000230557-25-000019.md) | [387 d](/filings/0000230557-25-000025.md) | [332 d](/filings/0000230557-26-000006.md) | [284](/filings/0000230557-26-000011.md) | [167 d](/filings/0000230557-26-000020.md) | [406 d](/filings/0000230557-26-000027.md) | [376 d](/filings/0000230557-26-000006.md) | [221](/filings/0000230557-26-000011.md) | [229 d](/filings/0000230557-26-000020.md) | [367 d](/filings/0000230557-26-000027.md) |
| Capital expenditure | $m | [7.9 d](/filings/0000230557-26-000006.md) | [6.2](/filings/0000230557-25-000010.md) | [7.7 d](/filings/0000230557-25-000019.md) | [9.4 d](/filings/0000230557-25-000025.md) | [7.5 d](/filings/0000230557-26-000006.md) | [13.0](/filings/0000230557-26-000011.md) | [7.2 d](/filings/0000230557-26-000020.md) | [8.5 d](/filings/0000230557-26-000027.md) | [10.0 d](/filings/0000230557-26-000006.md) | [10.9](/filings/0000230557-26-000011.md) | [14.1 d](/filings/0000230557-26-000020.md) | [20.3 d](/filings/0000230557-26-000027.md) |
| Dividends paid | $m | [20.7 d](/filings/0000230557-26-000006.md) | [20.8](/filings/0000230557-25-000010.md) | [20.8 d](/filings/0000230557-25-000019.md) | [20.8 d](/filings/0000230557-25-000025.md) | [22.6 d](/filings/0000230557-26-000006.md) | [22.3](/filings/0000230557-26-000011.md) | [22.9 d](/filings/0000230557-26-000020.md) | [22.5 d](/filings/0000230557-26-000027.md) | [25.2 d](/filings/0000230557-26-000006.md) | [24.8](/filings/0000230557-26-000011.md) | [25.0 d](/filings/0000230557-26-000020.md) | [24.8 d](/filings/0000230557-26-000027.md) |
| Share repurchases | $m | [0.1 d](/filings/0000230557-26-000006.md) | [6.7](/filings/0000230557-25-000010.md) | [0.0 d](/filings/0000230557-25-000019.md) | [8.8 d](/filings/0000230557-25-000025.md) | [0.1 d](/filings/0000230557-26-000006.md) | [25.2](/filings/0000230557-26-000011.md) | [0.3 d](/filings/0000230557-26-000020.md) | [36.6 d](/filings/0000230557-26-000027.md) | [30.5 d](/filings/0000230557-26-000006.md) | [35.0](/filings/0000230557-26-000011.md) | [32.4 d](/filings/0000230557-26-000020.md) | [55.6 d](/filings/0000230557-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [60.9](/filings/0000230557-24-000012.md) | [60.9](/filings/0000230557-24-000021.md) | [61.0](/filings/0000230557-24-000026.md) | [61.2](/filings/0000230557-25-000010.md) | [60.9](/filings/0000230557-25-000019.md) | [61.3](/filings/0000230557-25-000025.md) | [61.3](/filings/0000230557-26-000011.md) | [61.3](/filings/0000230557-26-000020.md) | [61.0](/filings/0000230557-26-000027.md) | [60.5](/filings/0000230557-26-000011.md) | [60.2](/filings/0000230557-26-000020.md) | [59.9](/filings/0000230557-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,996,229 at 2026-10-16, from the cover of the [10-Q filed 2026-10-23](/filings/0000230557-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.